Cancer Drug vs Chemotherapy: 90% vs 10% in Early Test

What if cancer could be treated without destroying the rest of your body?

In this episode, biotech founder Brad Niles (CEO of ARIZ Precision Medicine) breaks down a potential breakthrough in cancer treatment—one that targets cancer cells with precision instead of the “poison everything” approach of traditional chemotherapy.

In early testing, his team saw:
👉 90% cancer cell kill rate
👉 With only ~10% impact on healthy cells

If that holds up… it could change everything.

We dive into:
• Why chemotherapy hasn’t changed much in 100+ years
• What “RNA-based precision medicine” actually means (in plain English)
• How scientists are targeting the genetic drivers of cancer
• The long road from lab discovery to human trials
• Why AI is accelerating drug discovery faster than ever

This is one of those conversations that makes you think:
Are we closer than ever to beating cancer?

Learn more:
Website: https://arizbio.com/
LinkedIn: https://www.linkedin.com/company/arizbio/
LinkedIn: https://www.linkedin.com/in/brad-niles/
Instagram: https://www.instagram.com/arizprecisionmedicine/
Facebook: https://www.facebook.com/arizprecisionmedicine
______________________________________________________________

If this episode inspires you to be part of the movement, and you believe, like me, that entrepreneurs are the answer to our future, message me so we can join forces to support building truly great companies in our region. 
-
Subscribe to my channel here: https://www.youtube.com/channel/UCom_​... 
-  
Mark Haney is a serial entrepreneur that has experience growing companies worth hundreds of millions of dollars. He is currently the CEO and founder of HaneyBiz 
-  
Instagram: http://instagram.com/themarkhaney​ 
Facebook: www.facebook.com/themarkhaney 
LinkedIn: https://www.linkedin.com/in/markehaney​ 
Website: http://haneybiz.com​ 
Audio Boom: https://audioboom.com/channels/5005273​  
Twitter: http://twitter.com/themarkhaney
-
This video includes personal knowledge, experiences, and opinions about Angel Investing by seasoned angel investors.  This content is for informational purposes only and should not be construed as legal, tax, investment, or financial advice.  Nothing in this video constitutes a solicitation, recommendation, or endorsement.

#thebackyardadvantage #themarkhaneyshow #entrepreneur 
#PowerOfWith #SacramentoEntrepreneur #Sacramento
#SacramentoSmallBusiness #SmallBusiness #GrowthFactory #Investor
#Podcast